Boehringer Ingelheim is a global, research-driven pharmaceutical company that focuses on developing innovative treatments to improve the health and well-being of people and animals.

Founded in 1885, the company is one of the largest pharmaceutical firms in the world, with a strong emphasis on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.

Boehringer Ingelheim’s human pharmaceuticals division focuses on areas such as oncology, cardiovascular diseases, respiratory diseases, immunology, and diabetes. The company is known for its pioneering work in the development of biologic treatments, targeted therapies, and innovative drug delivery systems. It strives to address unmet medical needs by creating groundbreaking medicines that improve patient outcomes.

In addition to human health, Boehringer Ingelheim has a significant presence in animal health, producing vaccines, medications, and health products for livestock, pets, and other animals. The company’s research in this area supports the well-being of both domestic and agricultural animals, with a focus on preventing and treating diseases, enhancing productivity, and ensuring sustainable farming practices.

Boehringer Ingelheim operates globally, with a strong commitment to research and development (R&D), investing a significant portion of its revenue into advancing medical science. The company’s mission is to enhance quality of life by delivering innovative therapies and contributing to the global fight against diseases.